Related references
Note: Only part of the references are listed.Heme Oxygenase-1 Is Upregulated during Differentiation of Keratinocytes but Its Expression Is Dispensable for Cornification of Murine Epidermis
Marta Surbek et al.
Journal of Developmental Biology (2023)
Protective actions of nuclear factor erythroid 2-related factor 2 (NRF2) and downstream pathways against environmental stressors
Maria Teresa Bayo Jimenez et al.
FREE RADICAL BIOLOGY AND MEDICINE (2022)
Macrophage Migration Inhibitory Factor (MIF) and Its Homologue D-Dopachrome Tautomerase (DDT) Inversely Correlate with Inflammation in Discoid Lupus Erythematosus
Rosario Caltabiano et al.
MOLECULES (2021)
A structurally preserved allosteric site in the MIF superfamily affects enzymatic activity and CD74 activation in D-dopachrome tautomerase
Emily Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2021)
Hypersensitive IFN Responses in Lupus Keratinocytes Reveal Key Mechanistic Determinants in Cutaneous Lupus
Lam C. Tsoi et al.
JOURNAL OF IMMUNOLOGY (2019)
Evolving complexity of MIF signaling
Stanislovas S. Jankauskas et al.
CELLULAR SIGNALLING (2019)
The immunobiology of MIF: function, genetics and prospects for precision medicine
Insoo Kang et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Metascape provides a biologist-oriented resource for the analysis of systems-level datasets
Yingyao Zhou et al.
NATURE COMMUNICATIONS (2019)
Role of MIF and D-DT in immune-inflammatory, autoimmune, and chronic respiratory diseases: from pathogenic factors to therapeutic targets
Sven Gunther et al.
DRUG DISCOVERY TODAY (2019)
Discoid lupus erythematosus: Reflectance confocal microscopy features correlate with horizontal histopathological sections
Francesco Lacarrubba et al.
SKIN RESEARCH AND TECHNOLOGY (2019)
The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity
Allison C. Billi et al.
JCI INSIGHT (2019)
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-releasing molecule CORM-A1, in a murine model of autoimmune hepatitis
Katia Mangano et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa
Mrinal K. Sarkar et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets
Paolo Fagone et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
Severe recalcitrant cutaneous manifestations in systemic lupus erythematosus successfully treated with fumaric acid esters
A. M. Saracino et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Epidermal iron metabolism for iron salvage
Masayuki Asano et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2017)
MIF and D-DT are potential disease severity modifiers in male MS subjects
Gil Benedek et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Systematic integration of biomedical knowledge prioritizes drugs for repurposing
Daniel Scott Himmelstein et al.
ELIFE (2017)
Ultraviolet B Irradiation Causes Stimulator of Interferon Genes-Dependent Production of Protective Type I Interferon in Mouse Skin by Recruited Inflammatory Monocytes
Clayton Sontheimer et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1
Jianhua Liu et al.
ARTHRITIS & RHEUMATOLOGY (2017)
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Aravind Subramanian et al.
CELL (2017)
The therapeutic effect of CORM-3 on acute liver failure induced by lipopolysaccharide/D-galactosamine in mice
Bing-Zhu Yan et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2016)
CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury
Lei Jiang et al.
INFLAMMATION RESEARCH (2016)
Carbon monoxide-releasing molecule-A1 (CORM-A1) improves clinical signs of experimental autoimmune uveoretinitis (EAU) in rats
Paolo Fagone et al.
CLINICAL IMMUNOLOGY (2015)
Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
Roberto Bomprezzi
THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2015)
Heme Oxygenase-1 As a Target for Drug Discovery
Roberto Motterlini et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Pharmacological application of carbon monoxide ameliorates islet-directed autoimmunity in mice via anti-inflammatory and anti-apoptotic effects
Ivana Nikolic et al.
DIABETOLOGIA (2014)
The classification and diagnosis of cutaneous lupus erythematosus
Annegret Kuhn et al.
JOURNAL OF AUTOIMMUNITY (2014)
Successful treatment of discoid lupus erythematosus with fumaric acid esters
Athanasios Tsianakas et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2014)
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis
Paolo Fagone et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Downregulation of the Inflammatory Response by CORM-3 Results in Protective Effects in a Model of Postmenopausal Arthritis
Lidia Ibanez et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
Therapeutic potential of carbon monoxide in multiple sclerosis
P. Fagone et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2012)
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
Melanie Merk et al.
CYTOKINE (2012)
Prevention of clinical and histological signs of proteolipid protein (PLP)-induced experimental allergic encephalomyelitis (EAE) in mice by the water-soluble carbon monoxide-releasing molecule (CORM)-A1
P. Fagone et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
MIF: a key player in cutaneous biology and wound healing
Stephen C. Gilliver et al.
EXPERIMENTAL DERMATOLOGY (2011)
The CO-releasing molecule CORM-3 protects against articular degradation in the K/BxN serum transfer arthritis model
Nuria Maicas et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
The therapeutic potential of carbon monoxide
Roberto Motterlini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
MIF in autoimmunity and novel therapeutic approaches
Stanislava Stosic-Grujicic et al.
AUTOIMMUNITY REVIEWS (2009)
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
Juergen Bernhagen et al.
NATURE MEDICINE (2007)
Macrophage migration inhibitory factor deficiency attenuates macrophage recruitment, glomerulonephritis, and lethality in MRL/lpr mice
Alberta Y. Hoi et al.
JOURNAL OF IMMUNOLOGY (2006)
MIF:: a new cytokine link between rheumatoid arthritis and atherosclerosis
EF Morand et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Therapeutic applications of carbon monoxide-releasing molecules
R Motterlini et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Genetic dissection of systemic autoimmune disease in Nrf2-deficient mice
J Li et al.
PHYSIOLOGICAL GENOMICS (2004)
An automated method for finding molecular complexes in large protein interaction networks
GD Bader et al.
BMC BIOINFORMATICS (2003)
Bioactivity and pharmacological actions of carbon monoxide-releasing molecules
R Motterlini et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
R Kleemann et al.
NATURE (2000)
Share Paper
